Skip to Main Content

Paper Details

Novel Alzheimer Disease Treatments and Reconsideration of US Pharmaceutical Reimbursement Policy.
JAMA
3
2023
Author NameAffiliation
Meredith B RosenthalHarvard School of Public Health
  • 1 - 1

Datasets

Release 1.2